Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.180
0.00 (0.00%)
Mar 24, 2026, 11:47 AM EDT - Market open
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $10.61 million as of March 24, 2026. Its market cap has decreased by -51.20% in one year.
Market Cap
10.61M
Enterprise Value
20.02M
1-Year Change
-51.20%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $10.61M, a decrease of -89.75%. That is a compound annual growth rate of -35.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 12.35M | -32.30% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Modular Medical | 14.24M |
| Trinity Biotech | 11.92M |
| Lifeward | 10.30M |
| Sintx Technologies | 10.26M |
| PAVmed | 9.75M |
| Beyond Air | 8.31M |
| HeartSciences | 8.12M |
| Nexalin Technology | 8.02M |